171 related articles for article (PubMed ID: 27671818)
1. Therapeutic Potential and Molecular Targets of Piceatannol in Chronic Diseases.
Surh YJ; Na HK
Adv Exp Med Biol; 2016; 928():185-211. PubMed ID: 27671818
[TBL] [Abstract][Full Text] [Related]
2. Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives.
Kundu JK; Surh YJ
Cancer Lett; 2008 Oct; 269(2):243-61. PubMed ID: 18550275
[TBL] [Abstract][Full Text] [Related]
3. Biological activity of piceatannol: leaving the shadow of resveratrol.
Piotrowska H; Kucinska M; Murias M
Mutat Res; 2012; 750(1):60-82. PubMed ID: 22108298
[TBL] [Abstract][Full Text] [Related]
4. Exploring the therapeutic potential of naturally occurring piceatannol in non-communicable diseases.
Gandhi H; Mahant S; Sharma AK; Kumar D; Dua K; Chellappan DK; Singh SK; Gupta G; Aljabali AAA; Tambuwala MM; Kapoor DN
Biofactors; 2024; 50(2):232-249. PubMed ID: 37702264
[TBL] [Abstract][Full Text] [Related]
5. Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts.
Wieder T; Prokop A; Bagci B; Essmann F; Bernicke D; Schulze-Osthoff K; Dörken B; Schmalz HG; Daniel PT; Henze G
Leukemia; 2001 Nov; 15(11):1735-42. PubMed ID: 11681415
[TBL] [Abstract][Full Text] [Related]
6. Potential cancer-chemopreventive activities of wine stilbenoids and flavans extracted from grape (Vitis vinifera) cell cultures.
Waffo-Téguo P; Hawthorne ME; Cuendet M; Mérillon JM; Kinghorn AD; Pezzuto JM; Mehta RG
Nutr Cancer; 2001; 40(2):173-9. PubMed ID: 11962253
[TBL] [Abstract][Full Text] [Related]
7. Pro- and anticarcinogenic mechanisms of piceatannol are activated dose dependently in MCF-7 breast cancer cells.
Vo NT; Madlener S; Bago-Horvath Z; Herbacek I; Stark N; Gridling M; Probst P; Giessrigl B; Bauer S; Vonach C; Saiko P; Grusch M; Szekeres T; Fritzer-Szekeres M; Jäger W; Krupitza G; Soleiman A
Carcinogenesis; 2010 Dec; 31(12):2074-81. PubMed ID: 19696164
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells.
Wang TT; Schoene NW; Kim YS; Mizuno CS; Rimando AM
Mol Nutr Food Res; 2010 Mar; 54(3):335-44. PubMed ID: 20077416
[TBL] [Abstract][Full Text] [Related]
9. Piceatannol induces heme oxygenase-1 expression in human mammary epithelial cells through activation of ARE-driven Nrf2 signaling.
Lee HH; Park SA; Almazari I; Kim EH; Na HK; Surh YJ
Arch Biochem Biophys; 2010 Sep; 501(1):142-50. PubMed ID: 20558128
[TBL] [Abstract][Full Text] [Related]
10. Overview of Cellular Mechanisms and Signaling Pathways of Piceatannol.
Cao Y; Smith W; Yan L; Kong L
Curr Stem Cell Res Ther; 2020; 15(1):4-10. PubMed ID: 30947674
[TBL] [Abstract][Full Text] [Related]
11. Piceatannol inhibits mast cell-mediated allergic inflammation.
Ko YJ; Kim HH; Kim EJ; Katakura Y; Lee WS; Kim GS; Ryu CH
Int J Mol Med; 2013 Apr; 31(4):951-8. PubMed ID: 23426871
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of piceatannol against beta-amyloid-induced neuronal cell death.
Kim HJ; Lee KW; Lee HJ
Ann N Y Acad Sci; 2007 Jan; 1095():473-82. PubMed ID: 17404060
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol and cellular mechanisms of cancer prevention.
Shukla Y; Singh R
Ann N Y Acad Sci; 2011 Jan; 1215():1-8. PubMed ID: 21261635
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol structure and ceramide-associated growth inhibition in prostate cancer cells.
Sala G; Minutolo F; Macchia M; Sacchi N; Ghidoni R
Drugs Exp Clin Res; 2003; 29(5-6):263-9. PubMed ID: 15134383
[TBL] [Abstract][Full Text] [Related]
15. Regulation of p53 and cell proliferation by resveratrol and its derivatives in breast cancer cells: an in silico and biochemical approach targeting integrin αvβ3.
Hsieh TC; Wong C; John Bennett D; Wu JM
Int J Cancer; 2011 Dec; 129(11):2732-43. PubMed ID: 21225623
[TBL] [Abstract][Full Text] [Related]
16. Involvement of heme oxygenase-1 expression in neuroprotection by piceatannol, a natural analog and a metabolite of resveratrol, against glutamate-mediated oxidative injury in HT22 neuronal cells.
Son Y; Byun SJ; Pae HO
Amino Acids; 2013 Aug; 45(2):393-401. PubMed ID: 23712764
[TBL] [Abstract][Full Text] [Related]
17. Induction of apoptosis by a stilbene analog involves Bax translocation regulated by p38 MAPK and Akt.
So KS; Oh JE; Han JH; Jung HK; Lee YS; Kim SH; Chun YJ; Kim MY
Arch Pharm Res; 2008 Apr; 31(4):438-44. PubMed ID: 18449500
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol for breast cancer prevention and therapy: Preclinical evidence and molecular mechanisms.
Sinha D; Sarkar N; Biswas J; Bishayee A
Semin Cancer Biol; 2016 Oct; 40-41():209-232. PubMed ID: 26774195
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol and chemoprevention.
Goswami SK; Das DK
Cancer Lett; 2009 Oct; 284(1):1-6. PubMed ID: 19261378
[TBL] [Abstract][Full Text] [Related]
20. From French Paradox to cancer treatment: anti-cancer activities and mechanisms of resveratrol.
Yang X; Li X; Ren J
Anticancer Agents Med Chem; 2014; 14(6):806-25. PubMed ID: 24851878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
